6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
19m ago	Power Apps Adoption Outpaces Governance as Security and Compliance Risks Grow, Says Info-Tech Research Group
19m ago	Colgate-Palmolive Announces Webcast of its 2026 First Quarter Earnings Conference Call May 1, 2026 - Now at 8:00 a.m. ET and its 2026 Annual Meeting of Stockholders on May 8, 2026 at 10:00 a.m. ET
19m ago	Crexendo, Inc. to Issue First Quarter 2026 Financial Results on May 5, 2026, at 4:30 PM ET
19m ago	Focus Universal Inc. Announces Completed Acquisition of 901 Corporate Center Drive
45m ago	EXL recognized as 2025 Genesys New Partner of the Year

About

Monopar Therapeutics Inc (NASDAQ:MNPR) — investor relations, events, news, and company updates on 6ix.

Latest News

Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026

Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update

Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer

Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments

Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025

Financials

Revenue

$0

Market Cap

$359.23 M

EPS

-1.85

Community Chat

Ask AI